RGEN

Conviction 62HealthcareScan · Mon, Aug 10, 2026

RGEN$163.18-0.44%

ResistanceSupportVol 14Insider sellCongress buyCongress sell

Vol MA14 1.49M

May 11May 28Jun 16Jul 6Jul 23Aug 10

REPLIGEN CORPBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.repligen.com ↗

Price163.18

Change-0.44%

Gap-0.99%

Rel volume0.67×

Avg volume1.35M

Avg $ vol195.04M

SMA 20146.37

SMA 50138.69

SMA 200139.89

Price vs 50+17.66%

Price vs 200+16.65%

MA stackmixed

50/200 cross—

Supertrendup · 142.12

RSI (14)68

MACD hist2.13

MACD crossbull · 4d

Stoch %K / %D92 / 93

ADX (14)33

+DI / −DI39 / 11

RSI divergence—

MACD divergence—

ATR %+4.49%

ADR %4.92%

52w high172.26

52w low102.87

From 52w high-5.27%

Above 52w low+58.63%

New 52w highNo

SqueezeOff

Bollinger width24.76%

%B0.96

Donchian pos91.73%

Donchian high166.26

Donchian low129.00

AVWAP (52w high)131.54

vs AVWAP high+24.05%

AVWAP (52w low)132.97

vs AVWAP low+22.72%

OBV trendFlat

Chaikin MF (20)0.12

Today vs 20d0.67×

Avg vol (14d)1.49M

Avg vol (20d)1.35M

Avg $ vol (20d)195.04M

Market cap9.21B

RS 3m (vs SPY)+23.94%

RS 6m (vs SPY)+3.24%

RS line new highYes

Trend template6/8

Technical rank82.7

1 week+10.96%

1 month+13.13%

3 months+32.17%

6 months+14.77%

1 year+43.75%

YTD-0.71%

P/E188.35

P/B4.36

P/S65.20

P/FCF98.08

EPS0.8600

Div yield—

ROE2.31%

ROA1.66%

Debt/Eq0.26

Current9.05

EV/EBITDA68.35

Gross margin42.83%

Net margin34.62%

Rev growth35.10%

EPS growth291.64%

Price target172.45

Target upside5.68%

Analyst ratingBuy

Institutional125.97%

Ent. value9.15B

Revenue44.83M

Net income5.01M

Gross profit—

Free cash flow93.9M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out56.41M

Employees2K

ListedTue, Apr 29, 1986

Free float55.93M

Float %99.2%

Short interest5.81M

Days to cover7.9d

Short volume70.5%

Squeeze score66 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.54 vs $0.45

Last surprise+20.0% beat

Setup gradeB

Conviction62 / 100

Pattern quality—

Tech rank82.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance152.45

Support126.93

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 9 – Jun 10
2 scans
→
Breaking out now
Jun 11
1 scan
→
Setting up
Jun 12 – Jun 15
2 scans
→
Breaking out now
Jun 16
1 scan

Congress activity

Disclosed STOCK Act trades in RGEN · 6 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Lisa McClain house · MI · traded 2025-10-30	Sell	$1K–$15K	2025-10-30	2025-11-01	PDF
Lisa McClain house · MI · traded 2025-10-31	Sell	$1K–$15K	2025-10-31	2025-11-01	PDF
Lisa McClain house · R · MI · traded 2025-06-17	Sell	$1K–$15K	2025-06-17	2025-08-13	PDF
Lisa McClain house · R · MI · traded 2025-07-22	Buy	$1K–$15K	2025-07-22	2025-08-13	PDF
Lisa McClain house · R · MI · traded 2025-06-11	Buy	$1K–$15K	2025-06-11	2025-08-13	PDF
Jefferson Shreve house · R · IN · traded 2025-04-07	Sell	$15K–$50K	2025-04-07	2025-05-08	PDF

Insider activity

SEC Form 4 transactions in RGEN · 9 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Garland Jason K CFO · Common Stock · 2026-07-16	Sell	530	$80K	2026-07-16	2026-07-17
Konstantinov Konstantin Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18
DAWES KAREN A Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Konstantinov Konstantin Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Mhatre Rohin Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Pax Margaret Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
EGLINTON MANNER CARRIE Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
BARTHELEMY NICOLAS Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Madaus Martin D Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18
Pax Margaret Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18

SEC filings

EDGAR filings in RGEN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.